New review reveals how non-genomic estrogen signaling undermines treatment response and fuels tumor progression Hormone receptor–positive breast ...
We identified a large and rapidly growing cohort of people with MBC. The majority were initially diagnosed with non-metastatic breast cancer. Their demographic and clinical characteristics can be used ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results